Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM? M Van Woensel, N Wauthoz, R Rosière, K Amighi, V Mathieu, F Lefranc, ... Cancers 5 (3), 1020-1048, 2013 | 176 | 2013 |
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration M Van Woensel, N Wauthoz, R Rosière, V Mathieu, R Kiss, F Lefranc, ... Journal of Controlled Release 227, 71-81, 2016 | 158 | 2016 |
Sensitization of glioblastoma tumor micro-environment to chemo-and immunotherapy by Galectin-1 intranasal knock-down strategy M Van Woensel, T Mathivet, N Wauthoz, R Rosière, AD Garg, P Agostinis, ... Scientific Reports 7 (1), 1217, 2017 | 128 | 2017 |
New co‐spray‐dried tobramycin nanoparticles–clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients G Pilcer, R Rosière, K Traina, T Sebti, F Vanderbist, K Amighi Journal of pharmaceutical sciences 102 (6), 1836-1846, 2013 | 62 | 2013 |
Development of controlled-release cisplatin dry powders for inhalation against lung cancers V Levet, R Rosière, R Merlos, L Fusaro, G Berger, K Amighi, N Wauthoz International Journal of Pharmaceutics 515 (1), 209-220, 2016 | 58 | 2016 |
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy R Rosière, M Van Woensel, V Mathieu, I Langer, T Mathivet, ... International journal of pharmaceutics 501 (1), 148-159, 2016 | 42 | 2016 |
New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy R Rosière, M Gelbcke, V Mathieu, P Van Antwerpen, K Amighi, ... International journal of oncology 47 (3), 1131-1142, 2015 | 26 | 2015 |
Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties V Levet, R Merlos, R Rosière, K Amighi, N Wauthoz International Journal of Pharmaceutics 517 (1), 359-372, 2017 | 24 | 2017 |
Formulations Useful in the Treatment of Proliferative Diseases Affecting the Respiratory Tract K Amighi, R Rosiére, N Wauthoz, M Gelbecke US Patent App. 15/029,736, 2014 | 18* | 2014 |
New Dry Powders for Inhalation containing Chitosan Derivative-coated Solid Lipid Nanoparticles for Targeted Delivery to Lung Cancer Cells R Rosiere, K Amighi, M VERMEERSCH, N WAUTHOZ RDD Europe 2015, 447-452, 2015 | 9 | 2015 |
New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy R Rosière, M Van Woensel, V Mathieu, T Mathivet, K Amighi, N Wauthoz | 2* | |
Development of Folate Receptor-Targeted Nanoparticles Containing Temozolomide for Lung Cancers Therapy by Dry Powder Inhalation R Rosiere, N Wauthoz, P Van Antwerpen, M Gelbcke, K Amighi, R Dalby, ... Respiratory Drug Delivery 2014. Volume 3, 2014 | 1 | 2014 |
LOCAL AND SYSTEMIC PHARMACOKINETIC EVALUATION OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CISPLATIN DRY POWDERS FOR INHALATION AGAINST LUNG CANCER V Levet, R Rosiere, K Amighi, N Wauthoz JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 30 (4), A8-A9, 2017 | | 2017 |
Abstracts from The Aerosol Society Drug Delivery to the Lungs 27 Edinburgh International Conference Centre Edinburgh, Scotland, UK December 7–9, 2016 SP Newman, I Sibum, F Grasmeijer, P Hagedoorn, HW Frijlink, N Alizoti, ... Journal of Aerosol Medicine and Pulmonary Drug Delivery 30 (4), A-1-A-30, 2017 | | 2017 |
DEVELOPMENT OF DRY POWDER FORMULATIONS FOR INHALATION BASED ON NANOMEDICINE FOR TARGETED LUNG CANCER THERAPY R Rosiere, K Amighi Université libre de Bruxelles, 2016 | | 2016 |
Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo-and immunotherapy for glioblastoma M van Woensel, N Wauthoz, R Rosiere, K Amighi, V Mathieu, F Lefranc, ... | | 2014 |
Development of New Inhalable Formulations for the Lung Cancers Therapy R Rosiere, N Wauthoz, M Gelbcke, P Van Antwerpen, K Amighi | | 2013 |